Mechanism of Action

Nelotanserin is a a potent and highly selective inverse agonist of the 5HT2A receptor which reduces the activity of the 5HT2A receptor.

The 5HT2A receptor has been linked to neuropsychiatric disturbances including visual hallucinations. Axovant is developing nelotanserin as a potential treatment for Lewy body dementia.